Olaparib is a targeted cancer medication used primarily for the treatment of BRCA-mutated cancers, including ovarian, breast, pancreatic, and prostate cancer. As a PARP inhibitor, Olaparib helps block cancer cells from repairing their DNA, which slows their growth and encourages cell death. Visit: www.letsmeds.com Email us: [email protected] call/WhatsApp: +91-7428091874